Summarized by Masters of Longevity from PR Newswire.
Two treatment-resistant OCD patients had large symptom reductions after personalised iTBS.
Key Takeaways
- Two participants completed iTBS and showed large symptom reductions.
- One patient’s OCI-R score fell by 78 percent at treatment end.
- Two of four enrolled OCD participants withdrew before completing treatment.
